Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Considerations on delocalized HbA1c assays].

M Bordas-Fonfrède1, J Sélam, J Goudable

  • 1Laboratoire Central de Biochimie, Groupe Hospitalier Pitié-Salpêtrière, Paris.

Diabetes & Metabolism
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

Diabetes & metabolism·2025
Same author

Retraction Note: Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.

International journal of obesity (2005)·2024
Same author

Retraction Note: Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli.

International journal of obesity (2005)·2024
Same author

Real world evidence of the efficacy of two hybrid closed loop systems for children and adults with type 1 diabetes with some clinical warnings.

Diabetes & metabolism·2022
Same author

Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.

Diabetes & metabolism·2021
Same author

Hybrid closed Loop improved glucose control compared to sensor-augmented pumps in outpatients with type 1 diabetes in real-life conditions with telehealth monitoring.

Acta diabetologica·2021
Same journal

Glucagon-like peptide-1 receptor agonists and risk of pancreaticobiliary cancers in patients with type 2 diabetes: a nationwide cohort study.

Diabetes & metabolism·2026
Same journal

Decreased risk of new-onset osteoporosis in patients with Type 2 diabetes on SGLT-2 inhibitors.

Diabetes & metabolism·2026
Same journal

Two faces of autoimmune hyperinsulinemia: contrasting type B insulin resistance syndrome and exogenous insulin antibody syndrome.

Diabetes & metabolism·2026
Same journal

CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study.

Diabetes & metabolism·2026
Same journal

Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA Study.

Diabetes & metabolism·2026
Same journal

Blood oxygen saturation and its associations with autonomic and peripheral neuropathy in diabetes.

Diabetes & metabolism·2026
See all related articles

Delocalized hemoglobin A1c (HbA1c) testing improves diabetes management by informing therapy adjustments and patient motivation. These point-of-care assays require standardization and collaboration between clinicians and biologists for effective implementation.

Area of Science:

  • Clinical Chemistry
  • Point-of-Care Testing
  • Diabetes Management

Background:

  • Hemoglobin A1c (HbA1c) knowledge is crucial for diabetologists to optimize therapy and enhance patient motivation.
  • Delocalized HbA1c assays are requested to provide immediate results during consultations, similar to other point-of-care testing applications.
  • While not directly impacting life prognosis, delocalized testing offers significant clinical benefits.

Purpose of the Study:

  • To review the rationale behind implementing delocalized HbA1c assays.
  • To outline the steps involved in the practical implementation of these assays.
  • To emphasize the essential collaboration between clinicians and biologists for successful integration.

Main Methods:

  • Review of existing literature and guidelines on delocalized HbA1c testing.

Related Experiment Videos

  • Discussion of technical requirements for immunological delocalized assays, including standardization and quality control.
  • Consideration of practical aspects such as clinician expertise, biologist roles, and cost-effectiveness.

    • Main Results:

    • Immunological methods are a common solution for delocalized HbA1c testing.
    • These assays must adhere to laboratory standards and "Guide de Bonne Exécution des Analyses de Biologie Médicale" (GBEA) rules.
    • Successful implementation necessitates a balance between technical requirements, clinical utility, and economic viability.

    Conclusions:

    • Delocalized HbA1c assays offer valuable support for diabetes care by enabling timely therapeutic decisions and improving patient engagement.
    • The effective use of these point-of-care tests relies on rigorous standardization, quality control, and a strong collaborative framework between clinical and biological professionals.
    • Addressing practical constraints, including cost and specific expertise, is vital for widespread adoption and optimal patient outcomes.